News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search
here.
THE LATEST
Press Releases
Sernova Biotherapeutics Announces Warrant Amendments
February 20, 2026
·
3 min read
Press Releases
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the past.
February 20, 2026
·
8 min read
Press Releases
From AI-driven drug discovery to the era of “cell debugging.” - Commentary by Unexakorea
February 20, 2026
·
1 min read
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
·
1 min read
Press Releases
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
February 20, 2026
·
3 min read
Press Releases
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
February 20, 2026
·
1 min read
Press Releases
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
February 20, 2026
·
1 min read
Press Releases
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
February 20, 2026
·
10 min read
Press Releases
enGene to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
·
1 min read
Press Releases
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
February 20, 2026
·
1 min read
Press Releases
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
February 20, 2026
·
2 min read
Press Releases
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
February 20, 2026
·
6 min read
Press Releases
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
February 20, 2026
·
4 min read
Press Releases
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
February 20, 2026
·
4 min read
Press Releases
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
February 20, 2026
·
4 min read
Press Releases
Annual General Meeting in ALK-Abelló A/S on 16 March 2026
February 20, 2026
·
1 min read
Press Releases
Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
February 20, 2026
·
10 min read
Press Releases
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
February 20, 2026
·
2 min read
Press Releases
ABLi Therapeutics Announces Publication of the Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease
February 20, 2026
·
3 min read
Press Releases
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
February 20, 2026
·
5 min read
Press Releases
AltruBio Announces Formation of Inflammatory Bowel Disease Clinical Advisory Board
February 20, 2026
·
7 min read
Press Releases
Nasus Pharma to Participate in Upcoming Investor Conferences - February 20, 2026
February 20, 2026
·
1 min read
Press Releases
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2026
·
5 min read
Press Releases
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
·
5 min read
Press Releases
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
·
1 min read
Press Releases
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
February 5, 2026
·
6 min read
Press Releases
Tr1X Presents First Clinical Data Demonstrating Proof of Safety and Proof of Mechanism With Allogeneic Off-the-Shelf Tr1 Regulatory T Cell Therapy TRX103
February 5, 2026
·
5 min read
Press Releases
Affinia Therapeutics Announces FDA Acceptance of IND Application to Advance AFTX-201 to a Phase 1/2 Trial for the Treatment of BAG3-Associated Dilated Cardiomyopathy (DCM)
February 5, 2026
·
4 min read
Press Releases
Chamber Raises $60 Million in Series A Funding to Drive the Future of Cardiology Value-Based Care
February 5, 2026
·
3 min read
Press Releases
New Report Highlights CHOP’s Pioneering Approach to Advancing Pediatric Ventricular Recovery
February 5, 2026
·
4 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend - February 4, 2026
February 5, 2026
·
1 min read
Press Releases
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
February 5, 2026
·
3 min read
Press Releases
Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers
February 5, 2026
·
16 min read
Press Releases
Variable Rate of Anticoagulation Response to Direct Oral Anticoagulants (DOACs) in Acute Ischemic Stroke: The Potential of Point-of-Care DOAC Anticoagulation Measurement
February 5, 2026
·
4 min read